PetMeds Posts 31-Cent Quarterly Loss as Turnaround Pressure Mounts
PETS is trading near its 52-week low of $1.15 (5.2% above the low).
Summary
PetMed Express reported a second-quarter loss of $6.43 million, or 31 cents a share, on sales of $35.8 million. That follows a Q1 in which the company lost $6.1 million on net sales of $41.0 million, down 19.9% year over year, and burned $8.3 million in cash to end with just $13.1 million on hand. The loss keeps the pressure on new CEO Jeff Willard, who took over September 28, 2026, and on a cost-cutting plan management has leaned on to ease going-concern doubt. With the stock at $1.21 and a micro-cap valuation, another quarterly loss is a real balance-sheet issue, not just a headline miss.
At the time of this announcement, PETS was trading at $1.21 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $26.2M. The 52-week trading range was $1.15 to $4.10. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.